Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer.

MLA

Robbins, Jared R., et al. “Impact of Age-Adjusted Charlson Comorbidity Score on Outcomes for Patients with Early-Stage Endometrial Cancer.” Gynecologic Oncology, vol. 131, no. 3, Dec. 2013, pp. 593–97. EBSCOhost, https://doi.org/10.1016/j.ygyno.2013.10.007.

APA

Robbins, J. R., Gayar, O. H., Zaki, M., Mahan, M., Buekers, T., & Elshaikh, M. A. (2013). Impact of age-adjusted Charlson comorbidity score on outcomes for patients with early-stage endometrial cancer. Gynecologic Oncology, 131(3), 593–597. https://doi.org/10.1016/j.ygyno.2013.10.007

Chicago

Robbins, Jared R, Omar H Gayar, Mark Zaki, Meredith Mahan, Thomas Buekers, and Mohamed A Elshaikh. 2013. “Impact of Age-Adjusted Charlson Comorbidity Score on Outcomes for Patients with Early-Stage Endometrial Cancer.” Gynecologic Oncology 131 (3): 593–97. doi:10.1016/j.ygyno.2013.10.007.